ArticleJournal of translational medicine2026

A humanized LIF-targeting antibody synergistically enhances chemo- and immunotherapy in pancreatic cancer.

Fu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.